Democrats passed a $2.2 trillion pandemic aid bill; Ohio reports the deadliest overdose month in over a decade; the American Medical Association (AMA) asks for an abortion rule to be overturned.
On Thursday, House Democrats passed a $2.2 trillion coronavirus disease 2019 (COVID-19) relief bill over Republican opposition, The Washington Post reports. The legislation comes nearly 5 months after the House passed the HEROES Act, which did not progress in the Republican-controlled Senate. The current bill is also opposed by the Senate and White House, while Republicans condemned House Speaker Nancy Pelosi for pushing a bill that has no chance of becoming law instead of trying to reach a bipartisan deal. However, talks between Pelosi and Treasury Secretary Steven Mnuchin continue. The legislation allots money for stimulus checks, small businesses, unemployment insurance, and COVID-19 testing and treatment, and would provide aid to airlines and the Postal Service.
In May of 2020, at least 532 Ohioans died of a drug overdose, marking the highest total of any month in the past 14 years, according to The Columbus Dispatch. In comparison, data from the Ohio Department of Health’s mortality database show 381 residents died of an unintentional overdose in April 2020. Data from May are still incomplete though, as county coroners have 6 months to investigate the toll, meaning the number could still rise. The rate may be a potential side effect of the COVID-19 pandemic, as overdoses often climb in times of despair and economic uncertainty. Recently, the Ohio House and Senate passed a bill that expands access to naloxone, set to take effect on December 16.
The American Medical Association (AMA), the nation’s largest doctors’ group, asked the Supreme Court to strike down a Trump administration rule prohibiting taxpayer-funded clinics from referring women for abortions, the Associated Press reports. The ask comes after 2 US appeals courts issued conflicting rulings on the restriction. The clinics in question mainly serve low-income women. In addition to prohibiting clinics from referring women for abortions, the restriction also includes a mandate to financially and physically separate family planning facilities from those that provide abortion.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More